Orleans Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,246
| Closed | -$415K | – | 109 |
|
|
2025
Q1 | $415K | Buy |
3,246
+44
| +1% | +$5.63K | 0.24% | 70 |
|
|
2024
Q4 | $430K | Sell |
3,202
-50
| -2% | -$6.71K | 0.24% | 71 |
|
|
2024
Q3 | $473K | Buy |
3,252
+235
| +8% | +$34.2K | 0.27% | 65 |
|
|
2024
Q2 | $414K | Buy |
3,017
+62
| +2% | +$8.51K | 0.26% | 60 |
|
|
2024
Q1 | $405K | Buy |
+2,955
| New | +$405K | 0.27% | 59 |
|
|
2023
Q4 | – | Sell |
-2,515
| Closed | -$308K | – | 82 |
|
|
2023
Q3 | $308K | Buy |
+2,515
| New | +$308K | 0.23% | 62 |
|
|
2022
Q1 | – | Sell |
-4,960
| Closed | -$757K | – | 86 |
|
|
2021
Q4 | $757K | Sell |
4,960
-1,015
| -17% | -$155K | 0.43% | 47 |
|
|
2021
Q3 | $966K | Buy |
+5,975
| New | +$966K | 0.62% | 45 |
|
|
2018
Q1 | – | Sell |
-5,085
| Closed | -$543K | – | 83 |
|
|
2017
Q4 | $543K | Hold |
5,085
| – | – | 0.39% | 64 |
|
|
2017
Q3 | $565K | Buy |
5,085
+600
| +13% | +$66.7K | 0.42% | 57 |
|
|
2017
Q2 | $464K | Hold |
4,485
| – | – | 0.33% | 65 |
|
|
2017
Q1 | $438K | Buy |
4,485
+1,500
| +50% | +$146K | 0.31% | 67 |
|
|
2016
Q4 | $264K | Buy |
+2,985
| New | +$264K | 0.19% | 77 |
|